BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9436191)

  • 1. Indolent B-cell non-Hodgkin's lymphomas.
    Seng JE; Peterson BA
    Oncology (Williston Park); 1997 Dec; 11(12):1883-94, 1987; discussion 1901-2, 1. PubMed ID: 9436191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small B-cell lymphomas of the lymph nodes and spleen: practical insights to diagnosis and pathogenesis.
    Swerdlow SH
    Mod Pathol; 1999 Feb; 12(2):125-40. PubMed ID: 10071338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal lymphomas: the MALT concept.
    Isaacson PG
    Verh Dtsch Ges Pathol; 1992; 76():14-23. PubMed ID: 1283245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
    Weisenburger DD
    Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, pathology and treatment of non-follicular indolent lymphomas.
    Landgren O; Tilly H
    Leuk Lymphoma; 2008; 49 Suppl 1():35-42. PubMed ID: 18821431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin's lymphoma.
    Smith MR
    Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolent lymphomas of mature B lymphocytes.
    Kurtin PJ
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.
    Rosenwald A; Ott G; Stilgenbauer S; Kalla J; Bredt M; Katzenberger T; Greiner A; Ott MM; Gawin B; Döhner H; Müller-Hermelink HK
    Am J Pathol; 1999 Dec; 155(6):1817-21. PubMed ID: 10595910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary non-Hodgkin lymphoma of the stomach. A review with special reference to the MALT concept].
    Cogliatti SB; Schmid U
    Schweiz Med Wochenschr; 1994 Oct; 124(40):1764-74. PubMed ID: 7939542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura.
    Kambham N; Chang Y; Matsushima AY
    Clin Neuropathol; 1998; 17(6):311-7. PubMed ID: 9832258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
    Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
    Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal zone-related neoplasms of splenic and nodal origin.
    Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
    Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic lymphoid hemopathies in adults: chronic lymphocytic leukaemia and the phase of dissemination of small cell lymphomas].
    Geneviève F; Delisle V; Gardembas M; Foussard C; Gardais J; Zandecki M
    Ann Biol Clin (Paris); 2001; 59(4):403-15. PubMed ID: 11470635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolent nonfollicular lymphomas: characteristics, treatment, and outcome.
    Coiffier B; Thieblemont C; Felman P; Salles G; Berger F
    Semin Hematol; 1999 Apr; 36(2):198-208. PubMed ID: 10319388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathophysiology of indolent lymphoma.
    Capello D; Gaidano G
    Haematologica; 2000 Feb; 85(2):195-201. PubMed ID: 10681729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of histologically indolent non-Hodgkin's lymphomas.
    Solal-Celigny P
    Baillieres Clin Haematol; 1996 Dec; 9(4):669-87. PubMed ID: 9138612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.